Neurocrine Biosciences
NBIX
#1254
Rank
$14.14 B
Marketcap
$140.51
Share price
0.77%
Change (1 day)
50.05%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2023 (TTM): $0.33 B

According to Neurocrine Biosciences 's latest financial reports the company's current earnings (TTM) are $0.47 B. an increase over its 2022 earnings that were of $0.22 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 2001 to 2023

Annual earnings

Year Earnings Change
2023 $0.33 B52.44%
2022 $0.22 B73.74%
2021 $0.12 B-8.82%
2020 $0.13 B77.78%
2019 $78.46 M49.83%
2018 $52.37 M-142.57%
2017 -$0.13 B-14.73%
2016 -$0.15 B53.15%
2015 -$94.21 M46.25%
2014 -$64.42 M29.66%
2013 -$49.68 M-3530.8%
2012 $1.44 M-95.73%
2011 $33.92 M
2009 -$47.69 M-45.38%
2008 -$87.3 M-58.87%
2007 -$0.22 B87.3%
2006 -$0.12 B351.97%
2005 -$25.08 M-52.09%
2004 -$52.34 M-10.98%
2003 -$58.79 M
2001 -$43.89 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$3.26 B 588.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.25 B 1,216.62%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.56 B 1,492.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$36.72 M-92.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-$41.77 M-108.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.87 M-95.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$31.58 M-106.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.88 B 297.57%๐Ÿ‡ฌ๐Ÿ‡ง UK